Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma

JOURNAL ARTICLE published 1 November 2006 in Clinical Cancer Research

Authors: Janet E. Brown | Sue P. Ellis | Paul Silcocks | Aubrey Blumsohn | Sandra A. Gutcher | Clare Radstone | Barry W. Hancock | Matthew Q. Hatton | Robert E. Coleman

The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval

JOURNAL ARTICLE published 1 December 2020 in Clinical Cancer Research

Research funded by Cancer League of Colorado (193527-ZW) | Colorado Clinical & Translational Sciences Institute (CO-J-20-006) | NIH NCI (R00CA194318-03) | NIH NCI (R00CA193734) | NIH NCI (U01CA231978) | Department of Defense (OC130212) | Department of Defense (OC170228) | MD Anderson Cancer Center (# 5 P30 CA016672-40) | University of Colorado Cancer Center (P30CA046934)

Authors: Kimberly R. Jordan | Matthew J. Sikora | Jill E. Slansky | Angela Minic | Jennifer K. Richer | Marisa R. Moroney | Junxiao Hu | Rebecca J. Wolsky | Zachary L. Watson | Tomomi M. Yamamoto | James C. Costello | Aaron Clauset | Kian Behbakht | T. Rajendra Kumar | Benjamin G. Bitler

Tackling the Diversity of Triple-Negative Breast Cancer

JOURNAL ARTICLE published 1 December 2013 in Clinical Cancer Research

Authors: Nicholas C. Turner | Jorge S. Reis-Filho

HER-2 as a Target for Breast Cancer Therapy

JOURNAL ARTICLE published 15 March 2009 in Clinical Cancer Research

Authors: Michail Ignatiadis | Christine Desmedt | Christos Sotiriou | Evandro de Azambuja | Martine Piccart

DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer

JOURNAL ARTICLE published 1 September 2006 in Clinical Cancer Research

Authors: Jinsheng Yu | Mary A. Mallon | Wanghai Zhang | Robert R. Freimuth | Sharon Marsh | Mark A. Watson | Paul J. Goodfellow | Howard L. McLeod

Response to Combined Molecular Targeting: Defining the Role of P-STAT3

JOURNAL ARTICLE published 1 February 2011 in Clinical Cancer Research

Authors: Ann Marie Egloff | Jennifer R. Grandis

The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells

JOURNAL ARTICLE published 1 April 2011 in Clinical Cancer Research

Authors: Lucía López-Corral | Norma C. Gutiérrez | Maria Belén Vidriales | Maria Victoria Mateos | Ana Rasillo | Ramón García-Sanz | Bruno Paiva | Jesús F. San Miguel

Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma

JOURNAL ARTICLE published 15 August 2010 in Clinical Cancer Research

Authors: Nidia Y. Cerecer-Gil | Luis E. Figuera | Francisco J. Llamas | Mauricio Lara | José G. Escamilla | Ruben Ramos | Gerardo Estrada | A. Karim Hussain | José Gaal | Esther Korpershoek | Ronald R. de Krijger | Winand N.M. Dinjens | Peter Devilee | Jean Pierre Bayley

Distribution Patterns of Dendritic Cells and T Cells in Diffuse Large B-Cell Lymphomas Correlate with Prognoses

JOURNAL ARTICLE published 15 November 2007 in Clinical Cancer Research

Authors: Kung-Chao Chang | Guan-Cheng Huang | Dan Jones | Ya-Hui Lin

Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma

JOURNAL ARTICLE published 1 August 2020 in Clinical Cancer Research

Research funded by ClinicalTrials.gov (NCT03056599)

Authors: Kenneth R. Gundle | Gary B. Deutsch | Howard J. Goodman | Seth M. Pollack | Matthew J. Thompson | Jessica L. Davis | Mee-Young Lee | Daniel C. Ramirez | William Kerwin | Jessica A. Bertout | Marc O. Grenley | Kimberly H.W. Sottero | Emily Beirne | Jason Frazier | Joyoti Dey | Micah Ellison | Richard A. Klinghoffer | Robert G. Maki

Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

JOURNAL ARTICLE published 15 May 2023 in Clinical Cancer Research

Authors: Chong Kin Liam | Azura Rozila Ahmad | Te-Chun Hsia | Jianying Zhou | Dong-Wan Kim | Ross Andrew Soo | Ying Cheng | Shun Lu | Sang Won Shin | James Chih-Hsin Yang | Yiping Zhang | Jun Zhao | Karin Berghoff | Rolf Bruns | Andreas Johne | Yi-Long Wu

A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer

JOURNAL ARTICLE published 1 November 2022 in Clinical Cancer Research

Authors: Susana Banerjee | Vasiliki Michalarea | Joo Ern Ang | Alvaro Ingles Garces | Andrea Biondo | Ionut-Gabriel Funingana | Martin Little | Ruth Ruddle | Florence Raynaud | Ruth Riisnaes | Bora Gurel | Sue Chua | Nina Tunariu | Joanna C. Porter | Toby Prout | Mona Parmar | Anna Zachariou | Alison Turner | Ben Jenkins | Stuart McIntosh | Ed Ainscow | Anna Minchom | Juanita Lopez | Johann de Bono | Robert Jones | Emma Hall | Natalie Cook | Bristi Basu | Udai Banerji

Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells

JOURNAL ARTICLE published 1 February 2010 in Clinical Cancer Research

Authors: Lihua H. Wang | Thomas D. Pfister | Ralph E. Parchment | Shivaani Kummar | Larry Rubinstein | Yvonne A. Evrard | Martin E. Gutierrez | Anthony J. Murgo | Joseph E. Tomaszewski | James H. Doroshow | Robert J. Kinders

Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors

JOURNAL ARTICLE published 1 January 2016 in Clinical Cancer Research

Authors: Jeanette E. Eckel-Passow | Daniel J. Serie | John C. Cheville | Thai H. Ho | Sue M. Harrington | Tracy Hilton | Christine Lohse | Amanda Shreders | Payal Kapur | James Brugarolas | R Houston Thompson | Bradley C. Leibovich | Eugene D. Kwon | Richard W. Joseph | Alexander S. Parker

A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer

JOURNAL ARTICLE published 1 September 2023 in Clinical Cancer Research

Research funded by Fondazione AIRC 5 per mille (22759) | University of Padua (DOR funding) | University of Padua (DOR funding) | University of Padua (DOR funding)

Authors: Federica Miglietta | Moira Ragazzi | Bethania Fernandes | Gaia Griguolo | Davide Massa | Fabio Girardi | Michele Bottosso | Alessandra Bisagni | Giovanni Zarrilli | Francesca Porra | Daniela Iannaccone | Leocadia Dore | Mariangela Gaudio | Giacomo Santandrea | Matteo Fassan | Marcello Lo Mele | Rita De Sanctis | Alberto Zambelli | Giancarlo Bisagni | Valentina Guarneri | Maria Vittoria Dieci

Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients

JOURNAL ARTICLE published 15 December 2004 in Clinical Cancer Research

Authors: Naoko Takebe | Xiangfei Cheng | Suhlan Wu | Kenneth Bauer | Olga G. Goloubeva | Robert G. Fenton | Meyer Heyman | Aaron P. Rapoport | Ashraf Badros | John Shaughnessy | Douglas Ross | Barry Meisenberg | Guido Tricot

Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer

JOURNAL ARTICLE published 15 October 2018 in Clinical Cancer Research

Research funded by Breakthrough Breast Cancer (147) | Cancer Research UK (CRUK) (C30122/A11527) | Cancer Research UK (CRUK) (C30122/A15774) | Medical Research Council (MRC) (MR/L023091/1) | DH | National Institute for Health Research (NIHR) (IS-BRC-1215-20006) | Cancer Research UK (CRUK) (C10355/A15587) | Academy of Medical Sciences (Josephs)

Authors: Anthony Cheung | James Opzoomer | Kristina M. Ilieva | Patrycja Gazinska | Ricarda M. Hoffmann | Hasan Mirza | Rebecca Marlow | Erika Francesch-Domenech | Matthew Fittall | Diana Dominguez Rodriguez | Angela Clifford | Luned Badder | Nirmesh Patel | Silvia Mele | Giulia Pellizzari | Heather J. Bax | Silvia Crescioli | Gyula Petranyi | Daniel Larcombe-Young | Debra H. Josephs | Silvana Canevari | Mariangela Figini | Sarah Pinder | Frank O. Nestle | Cheryl Gillett | James F. Spicer | Anita Grigoriadis | Andrew N.J. Tutt | Sophia N. Karagiannis

Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia

JOURNAL ARTICLE published 1 December 2007 in Clinical Cancer Research

Authors: Marc R. Mansour | Veronique Duke | Letizia Foroni | Bella Patel | Christopher G. Allen | Phil J. Ancliff | Rosemary E. Gale | David C. Linch

Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer

JOURNAL ARTICLE published 15 October 2020 in Clinical Cancer Research

Research funded by HHS | NIH | National Cancer Institute (3P30 CA0062927)

Authors: Efrat Dotan | Dana B. Cardin | Heinz-Josef Lenz | Wells Messersmith | Bert O'Neil | Steven J. Cohen | Crystal S. Denlinger | Safi Shahda | Igor Astsaturov | Ann M. Kapoun | Rainer K. Brachmann | Shailaja Uttamsingh | Robert J. Stagg | Colin Weekes

A Model of Overall Survival Predicts Treatment Outcomes with Atezolizumab versus Chemotherapy in Non–Small Cell Lung Cancer Based on Early Tumor Kinetics

JOURNAL ARTICLE published 15 July 2018 in Clinical Cancer Research

Authors: Laurent Claret | Jin Y. Jin | Charles Ferté | Helen Winter | Sandhya Girish | Mark Stroh | Pei He | Marcus Ballinger | Alan Sandler | Amita Joshi | Achim Rittmeyer | David Gandara | Jean-Charles Soria | René Bruno